Raeliva

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutideCompounded · not FDA-approved
• Compounded tirzepatideCompounded · not FDA-approved
• Oral compounded GLP-1 (daily tablet)Compounded · not FDA-approved

What they publish

Raeliva publishes 8 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

None — states no membership fees, no consultation fees, no dose upcharges and no contract (as published)

Medication cost

Sold as one flat monthly price stated to include the medication, provider review and shipping, and to stay the same at every dose. The figures themselves were not published on the pages we captured. Advertises $20 off a first order (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

States it is cash-pay, that insurance plans generally do not cover compounded medications, and that every GLP-1 in a Raeliva programme is compounded. States it will provide an itemised receipt, and that an insurance-covered brand-name product is a separate path through a different provider.

HSA / FSA

States FSA and HSA cards are accepted.

Consultation process

Online intake reviewed by licensed providers, described as licensed in every US state, with the provider reviewing prescription history and eligibility. States there is no charge if you are found ineligible.

Eligibility

States providers are licensed in all fifty states, that it ships to all fifty states and not internationally, and that eligibility is a clinical decision made by the reviewing provider rather than a matter of location. Clinical criteria such as a BMI threshold were not published on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

States medication is prepared by licensed compounding pharmacies. The pharmacies are not named.

Shipping

States shipping is included in the flat monthly price, to all fifty US states only.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

States you can cancel at any time, with no contract and no pressure.

Refunds

States there is no charge if a provider finds you ineligible for treatment.

What stands out

• Publishes a footnote stating its patient-volume figure is cumulative across Pacific Shores Research Group telehealth platforms including onlinesemaglutide.org, is not a count of Raeliva patients alone, and does not represent typical results. Disclosing that a headline number is not what it appears to be is unusual, and it also reveals a corporate relationship most platforms leave unstated.
• States directly that every GLP-1 it offers is compounded and that insurance will not cover it, then points you elsewhere if you want a covered brand-name product. Sending a prospective customer away is not common here.
• Offers a daily oral tablet as well as weekly injections, and states the two differ in formulation, dosing, absorption, cost and expected results rather than presenting them as equivalent.
• The flat price is stated to hold at every dose, which removes the titration cost escalation.
• Discusses stepping down to a lower maintenance dose as a decision belonging with the treating provider, which is a more measured position than most marketing takes.
• No actual price figure appears on the pages we captured, so the 'one honest price' claim cannot be checked without starting the intake.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• What is the flat monthly price? The site describes the structure at length but publishes no figure on its public pages.
• Which compounding pharmacy prepares your medication?
• For the oral tablet, what evidence is there that the dose is absorbed at the level intended?
• What clinical criteria apply, given no BMI threshold is published?
• Is baseline lab work expected before starting?
• Compounded medication is not FDA-approved. Do you understand what that means for oversight and recourse?

Frequently asked